DNA RNA and Cells

03 Aug 2007 Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
02 Aug 2007 OncoGenex Initiates Phase I Clinical Trial of OGX-427 in Cancer
01 Aug 2007 OncoGenex and Isis Report Encouraging Interim Phase II Data in Advanced Prostate Cancer, Affirm Phase III Clinical Trial Plans
31 Jul 2007 Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
25 Jul 2007 Targeted Genetics' Inflammatory Arthritis Phase I/II Trial Placed on Clinical Hold
24 Jul 2007 Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Docetaxel trial
24 Jul 2007 Pluristem's PLX Cells Show Promise in Treating Limb Ischemia
21 Jul 2007 Expression Genetics, Inc. Announces Further Clinical Advancement of its Gene-Based IL-12 Therapy Co-administered with Standard Chemotherapy for Treatment of Ovarian Cancer
20 Jul 2007 EMEA Indicates that Genasense(R) Approval in Melanoma Will Require Confirmatory Clinical Trial
19 Jul 2007 FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
12 Jul 2007 Opko Health Initiates Phase 3 Trial of Bevasiranib for the Treatment of AMD
10 Jul 2007 Geron initiates clinical trial of Telomerase inhibitor drug in combination with Paclitaxel and ccarboplatin in patients with non-small cell lung cancer
08 Jul 2007 Cancer-fighting virus shows promise in early clinical trial
07 Jul 2007 siRNA collaboration with AstraZeneca
03 Jul 2007 Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
30 Jun 2007 Medistem Laboratories Announces Positive Preclinical Results for MDS-786 Candidate
29 Jun 2007 Titan Annnounces Completion of Patient Enrollment in Randomized Phase IIb Clinical Study of Spheramine(R) In Parkinson’s Disease
28 Jun 2007 First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
28 Jun 2007 Gentium's Defibrotide Seen as Active in Multiple Myeloma
26 Jun 2007 Alnylam Initiates Phase II Clinical Trial to Evaluate Safety and Anti-viral Efficacy of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus (RSV) Infection
25 Jun 2007 ADA Conference Presentations Highlight Isis' Metabolic Disease Program Research Activities
23 Jun 2007 Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
22 Jun 2007 Ceregene and Genzyme Announce Partnership for the Development and Commercialization of CERE-120 for Parkinson's Disease
22 Jun 2007 Oncolys BioPharma and Tacere Therapeutics form strategic alliance to develop RNAi Hepatitis C drug
22 Jun 2007 Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up